Technological advances in mucositis research: New insights and new issues-Reference-Cited by-同舟云学术

Technological advances in mucositis research: New insights and new issues

Published:2008-08 Issue:5 Volume:34 Page:476-482
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Gibson Rachel J.,Bowen Joanne M.,Keefe Dorothy M.K.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference65 articles.

1. Cytotoxic chemotherapy increases proapoptotic Bax and Bak expression in crypts of the rat and human small intestine;Bowen;Pathology,2005

2. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans;Keefe;Gut,2000

3. Gibson RJ. Chemotherapy induced mucositis: mechanisms of damage, time course of events and possible preventative strategies. PhD Thesis, Department of Medicine, University of Adelaide; 2004. p. 150.

4. Irinotecan causes severe small intestinal damage as well as colonic damage in the rat with implanted breast cancer;Gibson;J Gastroenterol Hepatol,2003

5. Mucositis: its occurrence, consequences, and treatment in the oncology setting;Pico;Oncologist,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the effect of honey and chlorhexidine on radiation-induced oral stomatitis with head-and-neck cancer patients;Archives of Medicine and Health Sciences;2023

2. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy;Anaerobe;2021-04

3. Сучасні погляди на проблему вторинних уражень слизової оболонки ротової порожнини як побічного ефекту комплексного протипухлинного лікування;Clinical Dentistry;2020-09-22

4. Troxerutin Prevents 5-Fluorouracil Induced Morphological Changes in the Intestinal Mucosa: Role of Cyclooxygenase-2 Pathway;Pharmaceuticals;2020-01-08

5. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases;European Journal of Pharmaceutical Sciences;2017-11